Ferring grants Dr. Frederik Paulsen Memorial Award in Japan
Copenhagen, Denmark – 22 September, 2003 –
Earlier this month, Ferring Pharmaceuticals granted the Dr. Frederik Paulsen Memorial Award in Neurosciences. The award winner, Dr. Yamashita from the Tokyo Medical and Dental University, received the award for the best poster at the World Congress of Neurohypophysis Research (WCNR) in Tokyo, Japan.
Dr. Yamashita’s poster described her research in identifying several proteins in the kidney that are involved in regulation of water transport in the kidney and concentration of urine.
‘Research in this area will hopefully in the future make it possible for us to further determine ways of modulating urine production, giving us safer and more predictable medicines in voiding dysfunction as Nocturia, bedwetting and possibly also incontinence,’ said Dr. Jens Peter Nørgaard, Executive Director, Medical Sciences, Urology.
The award was launched this year in the field of Neurohypophysis Research to commend scientific endeavours of special interest to Dr. Paulsen, the founder of Ferring. Dr. Paulsen was particularly intrigued by the pituitary gland and the use of neuropeptide hormones in medicines.
“Dr. Frederik Paulsen was a pioneer in this area. He welcomed the freedom to explore new avenues of research especially with regards to peptides,” said Dr. Nørgaard.
Many of Ferring’s products today are related to neurohypophysis work including vasopressin, oxytocin, growth hormone, ACTH, FSH and GNRH. “Ferring has been involved with multidisciplinary research since 1952 and has contributed to defining the impact that urinary production has for social continence”, said Dr. Nørgaard.
The WCNH aims to promote and advance the fields neurohypophysial hormones and related active substances in the brain, kidney and reproductive organs and to enhance the ties among scientists in the world.
About Ferring Pharmaceuticals
Ferring is a research driven, speciality biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of urology, obstetrics and infertility, gastroenterology and endocrinology. In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.
To learn more about Ferring or our products, please visit us at www.Ferring.com.